Kiora Pharmaceuticals Inc (KPRX)

12:44 PM

What drives Kiora Pharmaceuticals Inc. stock priceConsistent high-performance stocks - Autocar Professional

12:44 PM

06:30 AM

Kiora Pharmaceuticals Inc. Stock Analysis and ForecastExtraordinary market timing - Autocar Professional

06:30 AM

Jul 22, 2025

KPRX Receives Positive Outlook Following New U.S. Patent | KPRX Stock News - GuruFocus

Jul 22, 2025

Jul 22, 2025

Kiora Pharmaceuticals stock rises after receiving patent for KIO-104 By Investing.com - Investing.com Nigeria

Jul 22, 2025

Jul 22, 2025

Kiora Pharmaceuticals receives patent for ocular disease treatment - Investing.com

Jul 22, 2025

Jul 22, 2025

Kiora Secures Crucial Patent for Eye Disease Drug KIO-104 as Phase 2 Trial Advances - Stock Titan

Jul 22, 2025

Jul 21, 2025

What analysts say about Kiora Pharmaceuticals Inc. stockFree Expert Stock Watchlist - Autocar Professional

Jul 21, 2025

Jul 21, 2025

Is Kiora Pharmaceuticals Inc. a good long term investmentExceptional earning trajectories - jammulinksnews.com

Jul 21, 2025

Jul 17, 2025

Why Kiora Pharmaceuticals Inc. stock attracts strong analyst attentionFree Top-Rated Stock Analysis - Newser

Jul 17, 2025

Jul 17, 2025

Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know - MSN

Jul 17, 2025

Jul 16, 2025

Retinitis Pigmentosa Treatment Market Driven by Gene Therapy - openPR.com

Jul 16, 2025

Jul 15, 2025

How Kiora Pharmaceuticals Inc. stock performs during market volatilityFree Smart Money Stock Analysis - Newser

Jul 15, 2025

Jul 15, 2025

What makes Kiora Pharmaceuticals Inc. stock price move sharplyPredictable Return Stock Picks - Newser

Jul 15, 2025

Jul 09, 2025

Kiora Pharmaceuticals (NASDAQ:KPRX) Trading 1.8% Higher – Here’s Why - Defense World

Jul 09, 2025

Jun 17, 2025

Kiora Pharmaceuticals (NASDAQ:KPRX) Trading Down 0.3% – Here’s Why - Defense World

Jun 17, 2025

Jun 05, 2025

Kiora Pharmaceuticals and Senju Pharmaceutical partner on KIO-301 for retinal disease treatment in Asia - Ophthalmology Times

Jun 05, 2025

Jun 04, 2025

kiora pharmaceuticals reports results of annual shareholder meeting By Investing.com - Investing.com South Africa

Jun 04, 2025

Jun 04, 2025

kiora pharmaceuticals reports results of annual shareholder meeting - Investing.com

Jun 04, 2025

Jun 04, 2025

Kiora Pharmaceuticals Holds Annual Meeting, Elects Directors - TipRanks

Jun 04, 2025

Jun 04, 2025

Oil Prices Climb While US Equity Futures Stutter - Finimize

Jun 04, 2025

Jun 04, 2025

MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard SurgeMore Stocks Inside! - openPR.com

Jun 04, 2025

Jun 04, 2025

Pre-market Movers: STSS, SGMT, NIVF, OGEN... - RTTNews

Jun 04, 2025

Jun 04, 2025

MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard Surge – More Stocks Inside! - FinancialContent

Jun 04, 2025

Jun 04, 2025

Markets | American Financial Group, Inc. - FinancialContent

Jun 04, 2025

Jun 04, 2025

Kiora Pharmaceuticals inks potential $110 million deal with Senju By Investing.com - Investing.com South Africa

Jun 04, 2025

Jun 03, 2025

ReShape Lifesciences And Kiora Pharma Impress Investors, Dollar General Uplifts Outlook - Finimize

Jun 03, 2025

Jun 03, 2025

Sector Update: Health Care - marketscreener.com

Jun 03, 2025

Jun 03, 2025

Kiora Pharmaceuticals Stock Skyrockets Over 20% in Dynamic Trading Session - Daily Chhattisgarh News

Jun 03, 2025

Jun 03, 2025

Traws Pharma Inc. Stock Skyrockets Over 40%, Then Pares Gains in Volatile Trading - Daily Chhattisgarh News

Jun 03, 2025

Jun 03, 2025

Pre-market Movers: NIVF, TRAW, KKR, AGEN... - RTTNews

Jun 03, 2025

Jun 03, 2025

Kiora PharmaceuticalsEnters Exclusive Option Agreement With SenjuSEC Filing - marketscreener.com

Jun 03, 2025

Jun 03, 2025

Kiora Pharmaceuticals inks potential $110 million deal with Senju - Investing.com

Jun 03, 2025